Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 372, Pages eaag1286
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-01-12
DOI
10.1126/scitranslmed.aag1286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicity
- (2016) J. Mahlangu et al. HAEMOPHILIA
- Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity
- (2015) J. N. Mahlangu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models
- (2013) H. R. Stennicke et al. BLOOD
- Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database
- (2013) J. Puetz et al. HAEMOPHILIA
- Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry
- (2013) Loren Gragert et al. HUMAN IMMUNOLOGY
- Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
- (2013) S. Zollner et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A large synthetic peptide and phosphopeptide reference library for mass spectrometry–based proteomics
- (2013) Harald Marx et al. NATURE BIOTECHNOLOGY
- Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
- (2013) Simon D. van Haren et al. PLoS One
- Building better drugs: developing and regulating engineered therapeutic proteins
- (2013) Chava Kimchi-Sarfaty et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment
- (2013) Gouri Shankar Pandey et al. PLoS Computational Biology
- Plasma derivatives: New products and new approaches
- (2012) Zuben E. Sauna et al. BIOLOGICALS
- Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia
- (2012) J. N. MAHLANGU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain
- (2011) Eszter Herczenik et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacogenetics and the immunogenicity of protein therapeutics
- (2011) Chen Yanover et al. NATURE BIOTECHNOLOGY
- Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)
- (2009) M. CHITLUR et al. HAEMOPHILIA
- Robust Prediction of the MASCOT Score for an Improved Quality Assessment in Mass Spectrometric Proteomics
- (2008) Thomas Koenig et al. JOURNAL OF PROTEOME RESEARCH
- Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
- (2008) Morten Nielsen et al. PLoS Computational Biology
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
- (2008) Peng Wang et al. PLoS Computational Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started